Yanling Qu

Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4)

Litong Qi, Dexue Liu, Yanling Qu et al. · JACC Asia · 2023 · 27 citations · Full text

Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial

Yong Huo, Beijian Chen, Qiufang Lian et al. · The Lancet Regional Health - Western Pacific · 2023 · 27 citations · Full text

Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab

Yanyan Zhang, Zhaohui Pei, Beijian Chen et al. · Pharmacological Research · 2024 · 12 citations · Full text